These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16344314)

  • 1. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.
    Luthra R; Wu TT; Luthra MG; Izzo J; Lopez-Alvarez E; Zhang L; Bailey J; Lee JH; Bresalier R; Rashid A; Swisher SG; Ajani JA
    J Clin Oncol; 2006 Jan; 24(2):259-67. PubMed ID: 16344314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of response to preoperative chemoradiation in esophageal cancers.
    Luthra R; Luthra MG; Izzo J; Wu TT; Lopez-Alvarez E; Malhotra U; Choi IS; Zhang L; Ajani JA
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S2-5. PubMed ID: 17178277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancers.
    Luthra MG; Ajani JA; Izzo J; Ensor J; Wu TT; Rashid A; Zhang L; Phan A; Fukami N; Luthra R
    Clin Cancer Res; 2007 Feb; 13(3):912-9. PubMed ID: 17289885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.
    Rohatgi P; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh GL; Vaporciyan AA; Rice DC; Roth JA; Ajani JA
    Cancer; 2005 Dec; 104(11):2365-72. PubMed ID: 16245310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.
    Ajani JA; Mansfield PF; Crane CH; Wu TT; Lunagomez S; Lynch PM; Janjan N; Feig B; Faust J; Yao JC; Nivers R; Morris J; Pisters PW
    J Clin Oncol; 2005 Feb; 23(6):1237-44. PubMed ID: 15718321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
    Rohatgi PR; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh GL; Vaporciyan AA; Rice DC; Bresalier RS; Roth JA; Ajani JA
    Cancer; 2006 Feb; 106(3):552-8. PubMed ID: 16353210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
    Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
    J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer.
    Maher SG; Gillham CM; Duggan SP; Smyth PC; Miller N; Muldoon C; O'Byrne KJ; Sheils OM; Hollywood D; Reynolds JV
    Ann Surg; 2009 Nov; 250(5):729-37. PubMed ID: 19801928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Duong C; Greenawalt DM; Kowalczyk A; Ciavarella ML; Raskutti G; Murray WK; Phillips WA; Thomas RJ
    Ann Surg Oncol; 2007 Dec; 14(12):3602-9. PubMed ID: 17896157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of using biopsy samples from esophageal cancer for comprehensive gene expression profiling.
    Motoori M; Takemasa I; Yamasaki M; Komori T; Takeno A; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Matsuura N; Matsubara K; Monden M; Mori M; Doki Y
    Int J Oncol; 2009 Aug; 35(2):265-71. PubMed ID: 19578739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.
    Kang SY; Han JH; Lee KJ; Choi JH; Park JI; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Oh YT; Chun M; Kim JH; Sheen SS; Lim HY
    Clin Cancer Res; 2007 Jul; 13(14):4146-53. PubMed ID: 17634542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
    Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer.
    Chang EY; Smith CA; Corless CL; Thomas CR; Hunter JG; Jobe BA
    Am J Surg; 2007 May; 193(5):614-7; discussion 617. PubMed ID: 17434367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma.
    Ishibashi Y; Hanyu N; Nakada K; Suzuki Y; Yamamoto T; Yanaga K; Ohkawa K; Hashimoto N; Nakajima T; Saito H; Matsushima M; Urashima M
    Cancer Res; 2003 Aug; 63(16):5159-64. PubMed ID: 12941848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response.
    Langer R; Ott K; Specht K; Becker K; Lordick F; Burian M; Herrmann K; Schrattenholz A; Cahill MA; Schwaiger M; Hofler H; Wester HJ
    Clin Cancer Res; 2008 Dec; 14(24):8279-87. PubMed ID: 19088045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
    Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
    Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users.
    Suhr ML; Dysvik B; Bruland O; Warnakulasuriya S; Amaratunga AN; Jonassen I; Vasstrand EN; Ibrahim SO
    Oncol Rep; 2007 Nov; 18(5):1061-75. PubMed ID: 17914555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus.
    Lagarde SM; Ver Loren van Themaat PE; Moerland PD; Gilhuijs-Pederson LA; Ten Kate FJ; Reitsma PH; van Kampen AH; Zwinderman AH; Baas F; van Lanschot JJ
    Ann Surg Oncol; 2008 Dec; 15(12):3459-70. PubMed ID: 18825457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
    Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
    Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of early esophageal squamous cell carcinoma by cDNA microarray.
    Zhang X; Lin P; Zhu ZH; Long H; Wen J; Yang H; Zhang X; Wang DF; Fu JH; Fang Y; Rong TH
    Cancer Genet Cytogenet; 2009 Oct; 194(1):23-9. PubMed ID: 19737650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.